Glass2Med is a pioneer in advanced biomedical materials, dedicated to developing high-quality solutions for healthcare and beyond. Our portfolio includes bioactive glass, hydroxyapatite, β-TCP, and tetracalcium phosphate, with applications in regenerative medicine, dentistry, oral care, cosmetics, and personal care products. Available as versatile powders and granules, our materials support a wide range of R&D projects. With a specialized team driving innovation, we advance the development of safer, more effective, and personalized implants and medical devices, shaping the future of healthcare with scientific excellence and meaningful impact.
Glass2Med has recently submitted two projects for funding under the Portugal 2030 program, in response to the MPr-2023-7 call- SIID – Business R&D – Co-promotion Operations – Other Territories, and is currently awaiting the results.